mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: Effects of interferon-alpha (IFN-α) treatment

Clinical and Experimental Immunology

Volumn 114, Issue 1, 1998, Pages 55-60

  Shapiro, S ^a   Gershtein, V ^a   Elias, N ^b   Zuckerman, E ^b   Salman, N ^a   Lahat, N ^a,c  

^a Lady Davis Carmel Medical Centre   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cytokines; Hepatitis C virus; Interferon alpha therapy

Indexed keywords

ALPHA2A INTERFERON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIVER ENZYME; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOCYTE; PERSISTENT INFECTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS LOAD;

ANTIVIRAL AGENTS; CYTOKINES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LEUKOCYTES, MONONUCLEAR; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 0031708724     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00693.x     Document Type: Article

References (36)

1. Alter HJ, Purcell RH, Holland PV. Transmissible agent in non-A. non-B hepatitis. Lancet 1978; 1:459-63.
2. Van der Poel CL. Hepatitis C virus. Epidemiology, transmission and prevention. In: Reesink HW, ed. Hepatitis C virus. Current studies in hematology and blood transfusion. Basel: Karger 1994:137-69.
3. Saito I, Miyamura T, Ohbayashi A et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87:6547-9.
4. Chang TT, Young KC, Yang YJ, Lei HY, Wu HL. Hepatitis C virus RNA in peripheral blood mononuclcar cells: comparing acute and chronic hepatitis C virus infection. Hepatol 1996; 23:977-81.
5. Berenguer M, Olaso V, Cordoba J, Gohernado M, Carrasco D, Berenguer J. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 1995; 7:899-903.
6. Muratori L, Giostra F, Cataleta M, Francesconi R, Ballardini G, Cassani F, Lenzi M, Bianchi FB. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver 1994; 14:124-8.
7. Simmonds P. Variability of hepatitis C virus genome. In: Reesink HW, ed. Hepatitis C virus. Current studies in hematology and blood transfusion. Basel: Karger, 1994:1-11.
8. Choo SH, So HS, Cho JM, Ryu WS. Association of HCV particles with immunoglobulin: a mechanism for persistent infection. J Gen Virol 1995; 76:2337-41.
9. Higashi Y, Kakomu S, Yoshioka K et al. Dynamics of genome changes in the E2/NS1 regions of hepatilis C virus in-vivo. Virology 1993; 197:659-68.
10. Spengler V, Lechmann M, Irrgang B, Dumoulin FL, Sauerbruch T. Immune responses in hepatitis C virus infection. J Hepatol 1996; 24:20-25.
11. Rice CM, Walker CM, Hepatilis C virus specific T lymphocyte responses. Curr Opin Immunol 1995; 7:532-8.
12. Lechmann M. Inlenfeldt HG, Braunschweiger I et al. T and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus positive blood donors without viremia. Hepatology 1996; 24:790-5.
13. Pasi KJ, Evans JA, Wadhwa M, Thorpe R, Hill FG. Association of changes in monocyte antigen presentation and cytokine production in haemophilic boys with treatment and blood-borne virus infection. Br J Haematol 1995; 91:191-6.
14. Mendoza EC, Paglieroni TG, Zeldis JB. Decreased phorhol myristale acetate induced released of tumor necrosis factor alpha and interleukin 1 beta from peripheral blood monocytes of patients chronically infected with hepatitis C virus. J Infect Dis 1996; 179:842-4.
15. Torre D, Zeroli C, Gida M, Ferrario G, Fiori GP, Boretta G, Tambini R. Serum levels of IL-1α, IL-1β, IL-6 and TNF in patients with acute viral hepatitis. Clin Infec Dis 1994; 18:194-8.
16. + T cells, Immunol Today 1990; 11:55-59.
17. Biron CA. Cytokines in the generation of immune responses to and resolution of virus infection. Curr Opin Immunol 1994; 6:530-8.
18. Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995; 90:548-52.
19. Aledort LM. Consequences of chronic hepatitis C. A review article for the hematologist. Am J Hematol 1493; 44:29-37.
20. Ounanian A, Gueddah N, Rolachon A, Thelu MA, Zarski JF, Seigneurin JM. Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon. J Med Virol 1995; 45:141-5.
21. Takada A, Tsutsumi M, Okanoue T, Matsushima T, Komatsu M, Fujiyama S. Distribution of the different subtypes of hepatitis C virus in Japan and the effects of interferon: a nationwide survey. J Gastroenterol Hepatol 1996; 11:201-7.
22. Taliani G, Badolato C, Lecce R et al. Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment. J Med Virol 1995; 47:16-22.
23. Borden EC, Waalen J, Schreiber R, Williams B. Response and resistance to interferons and interacting cytokines. J Natl Cancer Inst 1995; 87:257-64.
24. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre and post-treatment with interferon α. Hepatology 1996; 24:6-9.
25. Missale G, Ferrari C, Fiaccadori F. Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int 1995; 10:14-18.
26. Corado JA, Toro FI, Baroja ML, Bianco NE, Machado IV. CD3- and CD28-activating pathways in HCV infection. Viral Immunol 1994; 7:37-40.
27. Kaempfer R. Regulation of the human interleukin-2/interleukin-2 receptor system: a role for immunosuppression. Proc Soc Exp Biol Med 1994; 203:176-80.
28. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 104:428-35.
29. + T cell clones. J Immunol 1988; 141:849-55.
30. Cleric M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection, Immunol Today 1993; 14:107-11.
31. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70:7092-102.
32. Larner AC, Petricoin EF, Nakagawa Y, Finbloom DS. IL-4 attenuates the transcriptional activation of both IFN-alpha and IFN-gamma induced cellular gene expression in monocytes and monocytic cell lines. J Immunol 1993; 150:1944-50.
33. Lohoff M, Marsig E. Rollinghoff M. Murine IL-4 antagonize the protective effects of αIFN on virus mediated lysis of murine L929 fibroblast cells. J Immunol 1990; 144:960-3.
34. Nickolaus P, Zawatzky R. Inhibition by IL-4 of constitutive beta-interferon synthesis in mouse macrophages. J Virol 1994; 68:6763-6.
35. Quiroga JA, Martin J, Pardo M, Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C and their relation to therapeutic response to interferon-α. Dig Dis Sci 1994; 39:2985-96.
36. Noguchi S, Sata M, Suzuki H, Ohba K, Mizokami M, Tanikawa K. Early therapy with interteron for acute hepatitis C acquired through a needlestick. Clin Infect Dis 1997; 24:992-4.